Albemarle to raise curative products capacity in Texas plant

Albemarle Corporation, a global provider of highly engineered specialty chemicals and services, is planning to increase production capabilities of its curatives products at its facility in Pasadena, Texas. The investment will support Albemarle's Ethacure 100 liquid curative product for application in polyureas, urethanes and epoxies. Production in the expanded facility is expected in 2015.
 
Albemarle's Ethacure 100 curatives are effective curing agents and chain extenders for polyurethane and polyurea elastomers, as well as epoxy resins, particularly in reaction injection moulding and spray applications. These diamine curatives allow for adjustable reaction time and substantially reduce dust exposure while providing processing advantages and improved final product properties.
 
“We are excited to announce our plans for increased production at a robust production site. This expansion will allow Albemarle to meet the needs of our customers by continuing to provide high quality products and customer service and will strengthen our position as a leading supplier in the curatives industry,” said Chris Knight, vice president, Specialty Chemicals, Albemarle.
 
Albemarle's Ethacure product line is globally recognised for its effectiveness in curing polyurethanes, epoxies and polyureas. The curatives business is part of the company's Performance Chemicals global business unit.